New SEC Form D filing

Estuary Biotherapeutics, Inc., 2026-10-16

A new SEC Form D private-offering notice from Menlo Park, CA, a $103,654,385 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Estuary Biotherapeutics, Inc. site↗ Verified via SEC Form D

Biotech developing AAV gene therapies to treat autosomal dominant polycystic kidney disease (ADPKD).

Filed 7 days agoFiled to raise $103,654,385First money in 2026-07-01Raised so far $40,654,685HQ (as filed) Menlo Park, CASector Biotech web-verified against the company’s own siteStage (inferred) LateCall status Late filing
Source linked the Form D on EDGAR↗Website verified estuarybio.com↗Named in the filing 4 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source